Sage Therapeutics Stock Predictions

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Sell

SAGE
Sage Therapeutics

Last Price:

$6.52

Seasonality Move:

-5.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Sage Therapeutics Stock Forecast

Over the next 52 weeks, Sage Therapeutics has on average historically risen by 11.6% based on the past 10 years of stock performance.
Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Sage Therapeutics Stock Undervalued?

The current Sage Therapeutics [SAGE] share price is $6.53. The Score for SAGE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
SAGE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Sage Therapeutics has on average historically risen by 11.6% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell

Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

sagerx.com

52-Week Data

52-Week High:

13.47

52-Week Low:

4.62

Prediction Charts

Market Cap:

408.9M

Price in USD:

6.53

Volume:

770.6K

Beta:

1.29

Technical Analysis

SMA50:

7.38

SMA100:

7.18

SMA200:

7.02

52-Wk Change:

-42.31%

Stock Predictions

Is Sage Therapeutics stock public?

Yes, Sage Therapeutics is a publicly traded company.
What is the Sage Therapeutics stock quote today?

The Sage Therapeutics stock price is 6.53 USD today.
How to buy Sage Therapeutics stock online?

You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-6	7.13	6.86	7.14	6.83
May-7	7.09	6.82	7.09	6.78
May-8	6.97	6.71	7.00	6.70
May-9	6.73	6.56	6.89	6.50
May-12	6.76	6.75	6.85	6.63
May-13	6.79	6.61	6.80	6.58
May-14	6.58	6.38	6.61	6.36
May-15	6.52	6.61	6.62	6.37
May-16	6.61	6.89	6.93	6.55
May-19	6.84	7.07	7.10	6.84
May-20	7.07	7.13	7.25	6.95
May-21	7.12	6.80	7.14	6.78
May-22	6.81	6.61	6.82	6.59
May-23	6.54	6.53	6.60	6.50

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.